DIVES MED Ami 100 5ml professional eye rejuvenation vial, featuring fragmented hyaluronic acid and amino acids to improve skin density.
DIVES MED – Ami Body (1x9ml)
DIVES MED – Ami Body (1x9ml)
DIVES MED Ami 100 5ml professional eye rejuvenation vial, featuring fragmented hyaluronic acid and amino acids to improve skin density.
DIVES MED – Ami Body (1x9ml)
DIVES MED – Ami Body (1x9ml)

DIVES MED AMI BODY 9ml

DIVES MED AMI BODY 9ml is an intensive professional tissue stimulator combining low-molecular-weight hyaluronic acid fragments (HAF) with amino-acid collagen promoters, developed to support firmness, elasticity, hydration and structural skin quality across facial and body treatment areas.

🔒 Professional Trade Account Required

Pricing, inventory details, and checkout options for clinical therapeutics, injectables, and advanced aesthetic elements are strictly restricted to verified healthcare professionals.

Log In | Apply for Access

DIVES MED AMI BODY 9ml

DIVES MED AMI BODY 9ml is an intensive professional tissue stimulator developed for treatment programmes focused on skin laxity, reduced firmness, elasticity and structural skin quality.

Part of the DIVES MED AMI range, AMI BODY combines fragmented hyaluronic acid (HAF) with amino-acid collagen promoters to provide a treatment concept extending beyond conventional hydration alone.

The formulation is specifically positioned for professional face and body firming treatments, with DIVES identifying areas including the face, neck, décolletage, abdomen, buttocks, hips, inner arms and thighs.

HAF – HYALURONIC ACID FRAGMENTS

The central technology within AMI BODY is fragmented hyaluronic acid (HAF) consisting of 20–38 monomers.

Unlike conventional high-molecular-weight hyaluronic acid used primarily for its water-binding properties, DIVES positions these low-molecular-weight HA fragments around both cellular hydration and modulation of the extracellular matrix.

The manufacturer states that HAF interacts with CD-44 receptors on fibroblasts, supporting processes associated with collagen and elastin biosynthesis and structural skin remodelling.

AMINO-ACID COLLAGEN SUPPORT

AMI BODY combines HAF with amino acids including lysine and glycine.

Amino acids are fundamental components of proteins and are incorporated into the formulation to complement the HAF technology within professional protocols focused on skin regeneration, hydration, elasticity and overall tissue quality.

BODY FIRMING & SKIN QUALITY

AMI BODY is particularly relevant where the treatment objective is not conventional facial volumisation but improvement in skin firmness and tissue quality across larger or more challenging body areas.

DIVES specifically positions the product for areas prone to visible laxity, including the abdomen, buttocks, hips, inner arms and thighs.

This makes AMI BODY a useful addition to professional body rejuvenation programmes where skin quality and firmness are being considered alongside other treatment modalities.

FACE, NECK & DÉCOLLETAGE

Despite the name AMI BODY, the official DIVES MED professional information also identifies the face, neck and décolletage as suitable treatment areas.

Its positioning therefore extends beyond body-only protocols, although its 9ml presentation makes it particularly relevant to larger treatment areas.

REGENERATIVE TREATMENT PLANNING

AMI BODY can sit within advanced professional treatment strategies where the objective is to improve the appearance of reduced firmness, laxity, dehydration and deteriorating skin quality.

Its combination of HAF technology and amino acids gives it a distinct position within the AMI range and separates it from conventional HA skin boosters whose primary treatment objective is hydration.

Technical Performance Profile

TREATMENT CONCEPT

Professional tissue stimulator developed around fragmented hyaluronic acid and amino-acid collagen support for face and body firming, hydration and structural skin-quality protocols.

CORE TECHNOLOGY

Hyaluronic Acid Fragments (HAF): 20–38 monomers

AMINO-ACID COLLAGEN PROMOTERS

Lysine, Glycine

PRODUCT VOLUME

1 × 9ml

PRIMARY TREATMENT OBJECTIVE

Skin Firmness, Elasticity, Hydration, Structural Skin Quality, Regenerative Skin Support

TREATMENT AREAS

Face, Neck, Décolletage, Buttocks, Hips, Abdomen, Inner Arms, Thighs

KEY BENEFITS

• Supports improvement in skin firmness
• Supports skin elasticity
• Supports cellular hydration
• Supports structural skin-quality programmes
• HAF technology based on 20–38 monomers
• Supports processes associated with collagen and elastin production
• Combines fragmented HA with amino-acid collagen promoters
• Suitable for facial and body protocols
• 9ml presentation suitable for larger treatment areas
• Suitable for regenerative and age-management treatment planning

IDEAL FOR

Skin Laxity, Reduced Firmness, Reduced Elasticity, Dehydrated Skin, Body Skin Rejuvenation, Abdomen, Inner Arms, Inner Thighs, Buttocks, Hips, Neck, Décolletage, Advanced Body Treatment Programmes

PROFESSIONAL APPLICATION

The manufacturer identifies AMI BODY for professional protocols including microneedle mesotherapy, needle-free mesotherapy, sonophoresis, iontophoresis and oxygen infusion.

I would keep this wording exactly at the manufacturer-supported level rather than adding our own injection technique or dosing instructions to the ecommerce page.

You May Also Like.

See what everyone is talking about. Explore the tried-and-true favorites loved by our community.

Keep Updated About Our Products

Premium NAD+ protocols, high-retention PMU pigments, and curated aesthetic essentials designed for transformative results.

You have been successfully Subscribed! Ops! Something went wrong, please try again.

Professional Trade Accounts Only

Access is restricted to verified practitioners. Qualification and insurance verification required before approval. Products are not available to members of the public.

Integra Aesthetics Group Ltd
Little Gable, High Street Godshill. Ventnor England, PO38 3HH United Kingdom

hello@integraaestheticspro.bwpsites.com

+44 7985 285766

© 2026 Brought to life by Innovenna